Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
(Image credit: Jodi Hilton for NPR)
Restrictions on obesity drug coverage force patients to pivot
Latest article
Greetings from an Islamabad park, a peaceful vantage point in an uncertain world
The park, near the venue where inconclusive Iran-U.S. peace talks took place this month, provides respite to those who visit it.
